Runnymede Capital Advisors’s Zoetis ZTS Stock Holding History

Runnymede Capital Advisors’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-23	Closed	-$3.75K	–	311
2024 Q4	$3.75K	Buy	+23	New	+$4.11K	﹤0.01%	235

Other funds holding ZTS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Runnymede Capital Advisors's ZTS Position: Q1 2025 in Review

Runnymede Capital Advisors sold out of Zoetis (ZTS) in Q1 2025, closing a stake of 23 shares — an estimated $3.75K sold.

Runnymede Capital Advisors first reported a position in ZTS in Q4 2024 and held it in 1 quarter. The position peaked at $3.75K in Q4 2024. 1,891 funds tracked by Wall St. Rank hold ZTS as of Q1 2025.

Runnymede Capital Advisors reported no remaining Zoetis position as of Q1 2025 after selling out during the quarter.
Runnymede Capital Advisors sold 23 Zoetis shares in Q1 2025, an estimated $3.75K.
Runnymede Capital Advisors first reported a position in Zoetis in Q4 2024 and held it in 1 quarter.
Runnymede Capital Advisors's Zoetis position peaked at $3.75K in Q4 2024.
1,891 funds tracked by Wall St. Rank held Zoetis as of Q1 2025.

Based on Runnymede Capital Advisors's 13F filing for Q1 2025, filed 22 Apr 2025.